Identification of Ganglioside GM3 Molecular Species in Human Serum Associated with Risk Factors of Metabolic Syndrome

• Lucas Veillon,

  Affiliation Division of Glycopathology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Pharmaceutical University, Sendai, Japan

  ⨯
• Shinji Go,

  Affiliation Division of Glycopathology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Pharmaceutical University, Sendai, Japan

  ⨯
• Wakana Matsuyama,

  Affiliation Division of Glycopathology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Pharmaceutical University, Sendai, Japan

  ⨯
• Akemi Suzuki,

  Affiliation Institute of Glycoscience, Tokai University, Kanagawa, Japan

  ⨯
• Mika Nagasaki,

  Affiliation Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

  ⨯
• Yutaka Yatomi,

  Affiliation Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

  ⨯
• Jin-ichi Inokuchi

  * E-mail: jin@tohoku-pharm.ac.jp

  Affiliation Division of Glycopathology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Pharmaceutical University, Sendai, Japan

  ⨯